STOCK TITAN

LXEO (NASDAQ: LXEO) Form 144: Insider files to sell 3,016 vested shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

LXEO notice of proposed sale of 3,016 common shares. The filing lists 3,016 shares as "Securities To Be Sold" with an event labeled Restricted Stock Vesting dated 02/17/2026. It also shows 721 common shares sold on 11/18/2025 as a prior three‑month disposition.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: A Form 144 records a proposed sale of 3,016 LXEO common shares tied to restricted stock vesting.

The filing lists 3,016 common shares under "Securities To Be Sold" with the transaction event described as Restricted Stock Vesting dated 02/17/2026. This indicates a holder intends to sell shares that vested on that date.

Prior activity shows 721 common shares sold on 11/18/2025. Cash‑flow treatment and purchaser details are not provided in the excerpt; subsequent filings may disclose execution details.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the LXEO Form 144 disclose about shares to be sold?

The Form 144 discloses a proposed sale of 3,016 common shares listed under "Securities To Be Sold" with an event labeled Restricted Stock Vesting dated 02/17/2026, indicating vested shares are the subject of the notice.

Does the filing show any recent LXEO share sales?

Yes. The filing shows a prior disposition of 721 common shares on 11/18/2025 recorded under "Securities Sold During The Past 3 Months." This appears as a historical sale entry in the notice.

Who is listed as the broker or intermediary in the LXEO filing?

The broker identified is Fidelity Brokerage Services LLC with an address at 900 Salem Street, Smithfield, RI; the excerpt lists this entity in the securities information section tied to the proposed sale.

Is the LXEO filing linked to compensation or vesting?

Yes. The filing describes the event as Restricted Stock Vesting dated 02/17/2026, indicating the shares listed for sale are tied to vested compensation awards rather than open‑market purchases.
Lexeo Therapeutics Inc

NASDAQ:LXEO

LXEO Rankings

LXEO Latest News

LXEO Latest SEC Filings

LXEO Stock Data

459.09M
67.58M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
NEW YORK